title: Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
authors.affiliation: Rhode Island Hospital, Division of Kidney Diseases and Hypertension, 593 Eddy Street, Providence, RI, 02903, USA.
authors.forename: Darbie
authors.initials: D
authors.lastname: Maccubbin
authors.forename: Diane
authors.initials: D
authors.lastname: Tipping
authors.forename: Olga
authors.initials: O
authors.lastname: Kuznetsova
authors.forename: William A
authors.initials: WA
authors.lastname: Hanlon
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Bostom
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000097:blood; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D054559:Hyperphosphatemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017674:Hypophosphatemia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D007211:Indoles / Q000627:therapeutic use; D007674:Kidney Diseases / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000009:adverse effects / Q000627:therapeutic use*; D010758:Phosphorus / Q000097:blood*; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D015415:Biomarkers; D003692:Delayed-Action Preparations; D000960:Hypolipidemic Agents; D007211:Indoles; C518174:MK-0524; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin; D009525:Niacin; D010758:Phosphorus; D002118:Calcium; C036293:prostaglandin D2 receptor